TPD52 antibody (AA 213-223)
Quick Overview for TPD52 antibody (AA 213-223) (ABIN1804466)
Target
See all TPD52 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 213-223
-
Specificity
- Human TPD52. This antibody is expected to recognise all three reported isoforms (NP_001020423.1, NP_001020424.1and NP_005070.1).
-
Purification
- Immunoaffinity purified
-
Immunogen
-
Synthetic peptide C-TEPLPEKTQES from the C-terminus of human TPD52 (NP_001020423.1 , NP_001020424.1, NP_005070.1). Percent identity with other species by BLAST analysis: Human (100%), Gorilla (91%), Orangutan (91%), Gibbon (91%), Monkey (91%), Marmoset (91%), Bovine (82%), Horse (82%).
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
- Approved: IHC, IHC-P (3.75 μg/mL), Peptide-ELISA (1:8000), WB (1 - 3 μg/mL)
-
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- Lot specific
-
Buffer
- Tris-buffered saline, pH 7.3, 0.5 % BSA, 0.02 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C. Avoid freeze-thaw cycles.
-
-
- TPD52 (Tumor Protein D52 (TPD52))
-
Alternative Name
- D52 / TPD52
-
Background
-
Name/Gene ID: TPD52
Synonyms: TPD52, D52, HD52, PrLZ, Prostate leucine zipper, Protein N8, Tumor protein D52, N8L, Pc-1 -
Gene ID
- 7163
-
NCBI Accession
- NP_001020423, NP_001020424, NP_005070
-
UniProt
- P55327
Target
-